Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

UNQ6411 Inhibitors

UNQ6411 inhibitors represent a class of compounds that interact specifically with the UNQ6411 protein or enzyme, modulating its activity by preventing its normal biological function. These inhibitors are designed based on the structural and functional properties of UNQ6411, which may have key roles in various biochemical pathways. The inhibitors are typically small molecules that bind to specific active sites on the UNQ6411 enzyme, disrupting its ability to catalyze reactions or mediate protein-protein interactions. Structural studies of the enzyme-inhibitor complex reveal critical binding domains, which guide the rational design of more potent and selective inhibitors. In many cases, high-throughput screening methods are used to identify lead compounds, and subsequent structural optimization helps enhance their binding affinity and specificity for UNQ6411. Advanced techniques, such as crystallography or cryo-electron microscopy, often provide detailed insight into the inhibitor binding modes, which is essential for understanding their mechanistic action.

The chemical structure of UNQ6411 inhibitors is typically characterized by distinct functional groups that enable strong interactions with the active site or allosteric regions of the target enzyme. These functional groups may include aromatic rings, amide linkages, or heterocyclic scaffolds, which confer both rigidity and flexibility, allowing the molecule to adapt to the enzyme's structural conformation. The inhibitors may also possess key hydrogen bond donors and acceptors, hydrophobic regions, and charged residues that facilitate specific molecular recognition and binding. Additionally, UNQ6411 inhibitors often undergo extensive characterization to evaluate their stability, solubility, and interaction with other biomolecules within a biological system. Understanding the physicochemical properties of these inhibitors is crucial for optimizing their binding efficiency and ensuring selectivity for UNQ6411 over other enzymes, thus minimizing off-target effects in complex biological environments.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Inhibits protein kinases which can regulate protein activity through phosphorylation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, which is often upstream of various signaling pathways that can regulate protein activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAP kinase, potentially affecting proteins regulated by stress-activated pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, which can affect protein synthesis and cellular growth pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, which is involved in the MAPK/ERK pathway, affecting proteins regulated by this pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K, affecting pathways that control various protein functions.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which could alter protein activity governed by stress responses.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits proteasome activity, potentially affecting protein degradation processes.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Inhibits proteasome, affecting protein turnover and function.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

Inhibits Aurora kinases, which can affect protein regulation during cell division.